About Us

  

CardioNXT is building a platform of products that enable a better understanding of complex cardiac arrhythmias such as Atrial Fibrillation, and furthermore deliver targeted therapy to affected areas within the heart.  In addition to providing next generation technology, CardioNXT products are designed to reduce the cost of cardiac catheter ablation procedures.  This attention to cost reduction will not only benefit the U.S. market, it will enable arrhythmia therapies to be adopted rapidly in global markets including underserved emerging markets. 

  

CardioNXT was founded in 2012 in Westminster, CO with the core belief that great things can be achieved when Doctors and Engineers work closely together. 

Cardionxt Team

Intellectual property portfolios

image1

image2

US 9,510,772

US 14/802,641

US 15/369,183

PCT/US2013/034789

JP 2015-505782

61/955,673

PCT/US2015/021435

EP 13775770.4

EP 15765634.9

62/197,263

62/197,264

62/197,265 

62/197,267

62/197,269

62/197,272

62/197,275 

62/197,276

PCT/US16/044228

WO 2015/14136

WO 2017/019754

62/747,508 


US 9,078,583 

US 9,498,143 

US 9,427,168 

US 9,955,893

US 9,763,588

US 10,143,393

61/868,950

14/466,588

14/737,116

14/703,532

US 15/355,909 

61/988,651

PCT/US2015/029031

EP 15788895.0 

EP 3035643

US 15/250,180 

15/250,180

15/707,587

15/966,842 

16/206,421

WO 2015/027191

Contact Us

General inquiries, please email info@cardionxt.com

CardioNXT, Inc.

12011 North Tejon Street, Denver, Colorado 80234, United States

Contact Us

Cancel

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.